{"id":3009,"date":"2021-12-01T12:56:34","date_gmt":"2021-12-01T16:56:34","guid":{"rendered":"https:\/\/www.atlanticpath.ca\/?p=3009"},"modified":"2023-02-27T11:30:16","modified_gmt":"2023-02-27T15:30:16","slug":"canpath-to-study-the-impact-and-immune-response-to-covid-19-infection-and-vaccination","status":"publish","type":"post","link":"https:\/\/www.atlanticpath.ca\/index.php\/2021\/12\/01\/canpath-to-study-the-impact-and-immune-response-to-covid-19-infection-and-vaccination\/","title":{"rendered":"CanPath to Study the Impact and Immune Response to COVID-19 Infection and Vaccination"},"content":{"rendered":"<p>The Government of Canada is investing $1.9m through the COVID-19 Immunity Task Force (CITF)\u00a0to fund an extension of CanPath\u2019s COVID-19 Antibody Study over a longer period of time, allowing for additional collection of blood samples and questionnaires. The CanPath COVID-19 Antibody Study is implemented in collaboration with CanPath\u2019s regional cohorts, including Atlantic PATH, CARTaGENE (Quebec), the Ontario Health Study, the Manitoba Tomorrow Project, Alberta&#8217;s Tomorrow Project, and the BC Generations Project.<\/p>\n<p>CanPath is a national population health research platform that follows the health of 330,000 volunteer Canadians (or approximately 1% of the population). Its pan-Canadian COVID-19 Antibody Study will now collect a second dried blood spot sample from over 20,000 Canadians, aged 30 and older. Researchers will test the samples for presence and level of antibodies to SARS-CoV-2, produced in response to either vaccination or past infection with the novel coronavirus.<\/p>\n<p>Please click here for additional details:\u00a0<a href=\"https:\/\/bit.ly\/3I6lWE5\">https:\/\/bit.ly\/3I6lWE5<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Government of Canada is investing $1.9m through the COVID-19 Immunity Task Force (CITF)\u00a0to fund an extension of CanPath\u2019s COVID-19 Antibody Study over a longer period of time, allowing for additional collection of blood samples and questionnaires. The CanPath COVID-19 Antibody Study is implemented in collaboration with CanPath\u2019s regional cohorts, including Atlantic PATH, CARTaGENE (Quebec), the Ontario Health Study, the Manitoba Tomorrow Project, Alberta&#8217;s Tomorrow Project, and the BC Generations Project. CanPath is a national population health research platform that follows the health of 330,000 volunteer Canadians (or approximately 1% of the population). Its pan-Canadian COVID-19 Antibody Study will now collect a second dried blood spot sample from over 20,000 Canadians, aged 30 and older. Researchers will test the samples for presence and level of antibodies to SARS-CoV-2, produced in response to either vaccination or past infection with the novel coronavirus. Please click here for additional details:\u00a0https:\/\/bit.ly\/3I6lWE5<\/p>\n","protected":false},"author":1,"featured_media":3011,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[3],"tags":[13,11,33,30],"class_list":["post-3009","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-atlantic-path","tag-canpath","tag-citf","tag-covid-19"],"acf":[],"modified_by":"pathwp","_links":{"self":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/comments?post=3009"}],"version-history":[{"count":1,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3009\/revisions"}],"predecessor-version":[{"id":3010,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/posts\/3009\/revisions\/3010"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/media\/3011"}],"wp:attachment":[{"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/media?parent=3009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/categories?post=3009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.atlanticpath.ca\/index.php\/wp-json\/wp\/v2\/tags?post=3009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}